Treatment of a metabolic liver disease by in vivo genome base editing in adult mice

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature Medicine

• Publication date

  2018-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41591-018-0209-1PMID 30297904
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy

  2018cited by this paper
• Base editing with a Cpf1–cytidine deaminase fusion

  2018cited by this paper
• In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing

  2017cited by this paper
• Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions

  2017cited by this paper
• Engineered Cpf1 variants with altered PAM specificities increase genome targeting range

  2017cited by this paper
• A communal catalogue reveals Earth’s multiscale microbial diversity

  2017cited by this paper
• Correction of a pathogenic gene mutation in human embryos

  2017cited by this paper
• Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents

  2017cited by this paper
• Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems

  2016cited by this paper
• Teleseismic S wave microseisms

  2016cited by this paper
• A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice

  2016cited by this paper
• CrispRVariants charts the mutation spectrum of genome engineering experiments

  2016cited by this paper
• Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

  2016cited by this paper
• Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

  2016cited by this paper
• Xenobiotics to the rescue

  2016cited by this paper
• Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR

  2016cited by this paper
• Engineered CRISPR-Cas9 nucleases with altered PAM specificities

  2015cited by this paper
• Crystal Structure of Staphylococcus aureus Cas9.

  2015cited by this paper
• Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition

  2015cited by this paper
• In vivo genome editing using Staphylococcus aureus Cas9

  2015cited by this paper
• Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.

  2015cited by this paper
• Development of an intein-mediated split–Cas9 system for gene therapy

  2015cited by this paper
• Phenotypic Reversion of Fair Hair upon Gene Therapy of the Phenylketonuria Mice

  2014cited by this paper
• Crystal structure of Cas9 in complex with guide RNA and target DNA.

  2014cited by this paper
• Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype

  2014cited by this paper
• Phenotypic reversion of fair hair upon gene therapy of the phenylketonuria mice.

  2014cited by this paper
• Treatment of phenylketonuria using minicircle‐based naked‐DNA gene transfer to murine liver

  2014cited by this paper
• Computationally designed liver-specific transcriptional modules and hyperactive factor IX improve hepatic gene therapy.

  2014cited by this paper
• PEAR: a fast and accurate Illumina Paired-End reAd mergeR

  2013cited by this paper
• Quantification of phenylalanine hydroxylase activity by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry.

  2012cited by this paper
• Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells.

  2012cited by this paper
• Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges

  2011cited by this paper
• Phenylalanine hydroxylase deficiency

  2011cited by this paper
• State-of-the-art gene-based therapies: the road ahead

  2011cited by this paper
• Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro.

  2010cited by this paper
• Phenylketonuria.

  2010cited by this paper
• Animal models of brain dysfunction in phenylketonuria.

  2010cited by this paper
• DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells

  2008cited by this paper
• Comparison of nonhomologous end joining and homologous recombination in human cells.

  2008cited by this paper
• Epilepsy in Phenylketonuria: A Complex Dependence on Serum Phenylalanine Levels

  2007cited by this paper
• Liver: An organ with predominant innate immunity

  2007cited by this paper
• Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer

  2006cited by this paper
• The liver as an immunological organ

  2006cited by this paper
• Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria

  2006cited by this paper
• Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway.

  2003cited by this paper
• Mouse models of human phenylketonuria.

  1993cited by this paper
• Phenylketonuria: epitome of human biochemical genetics (second of two parts).

  1980cited by this paper

• Split technology in CRISPR-Cas system for precision genome manipulation and diagnostics

  2026cites this paper
• Pediatric Full and In-situ Split Domino Living Donor Liver Transplants Experience.

  2026cites this paper
• Non-Viral delivery of genome-editing tools for treatment of genetic disorders

  2026cites this paper
• Fluorinated lipid nanoparticle-mediated mRNA delivery enables high-fidelity base editing for therapeutic reversal of hereditary tyrosinemia

  2026cites this paper
• Precision A3G Base Editors for Disease Modeling and Correction.

  2026cites this paper
• Phenotypic study of humanized mice carrying the PAH deep intronic variant c.1199+502A>T

  2025cites this paper
• Global research dynamics in urea cycle disorders: a bibliometric study highlighting key players and future directions

  2025cites this paper
• Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative disease

  2025cites this paper
• Characterization and treatment monitoring of ureagenesis disorders using stable isotopes

  2025cites this paper
• Application of Rational Design and Molecular Metadynamics for the Estimation of Changes in Trans-Splicing Efficiency during the Mutagenesis of Ssp DnaE Intein

  2025cites this paper
• Engineering of Peptide‐Inserted Base Editors with Enhanced Accuracy and Security

  2025cites this paper
• CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders

  2025cites this paper
• Prime Editing of Alzheimer's Disease High-Risk APOE4 Allele by Brain-Directed Adeno-Associated Virus Vectors.

  2025cites this paper
• Treatment of a metabolic liver disease in mice with a transient prime editing approach

  2025influential citation
• Efficient AAV8 delivery to the liver via isolated hepatic perfusion and analysis of hepatic lobule transduction patterns

  2025cites this paper
• Synthetic closed-loop gene circuit for phenylalanine regulation

  2025cites this paper
• Spatial profiling of gene editing by in situ sequencing in mice and macaques.

  2025cites this paper
• Prime editing of the β1 adrenoceptor in the brain restores physiological REM sleep in a mouse model of Alzheimer’s disease

  2025cites this paper
• CRISPR-Cas editing technologies for viral-mediated gene therapies of human diseases: Mechanisms, progress, and challenges

  2025cites this paper
• Evaluation and prediction of guide RNA activities in genome-editing tools

  2025cites this paper
• In vivo precision base editing to rescue mouse models of disease

  2025cites this paper
• Advancements in CRISPR/Cas systems for disease treatment

  2025cites this paper
• Integrating pharmacogenetics, multi‐omics and machine learning in the novel therapeutic view of pulmonary hypertension

  2025cites this paper
• Off-Target RNA Editing Hotspots Caused by Base Editors.

  2025cites this paper
• GFP-on mouse model for interrogation of in vivo gene editing

  2025cites this paper
• A Compact Base Editor Rescues AATD-associated Liver and Lung Disease in Mouse Models

  2025cites this paper
• Current Trends in Gene Therapy to Treat Inherited Disorders of the Brain.

  2025cites this paper
• High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics

  2025cites this paper
• Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group

  2025cites this paper
• The path to biotechnological singularity: Current breakthroughs and outlook.

  2025cites this paper
• Exploring Prime Editing strategies for genetic correction of a Ceroid Neuronal Lipofuscinosis type 2 disease causing variant

  2025cites this paper
• Predicting adenine base editing efficiencies in different cellular contexts by deep learning

  2025cites this paper
• In vivo delivery systems for CRISPR genome editing: Viral and non-viral carriers

  2025cites this paper
• Genomic insertion of ancestral uricase into human liver cells to determine metabolic consequences of pseudogenization

  2025cites this paper
• Advancements in Nonviral Gene Editing Strategies for Rare Diseases

  2025cites this paper
• A Compact Base Editor Rescues AATD-associated Liver and Lung Disease in Mouse Models.

  2025cites this paper
• Expanding the CRISPR/Cas toolkit: applications in proteomics and theranostics

  2025cites this paper
• An adeno-associated virus vector-based intracellular peptide delivery system for treating hepatocellular carcinoma with wild-type p53.

  2025cites this paper
• Research progress of base editing and prime editing tools based on the CRISPR/Cas system

  2025cites this paper
• Adenine base editor correction of pathogenic variations associated with inherited retinal dystrophy in patient iPSC and retinal organoids

  2025cites this paper
• Advancing Gene Therapy for Phenylketonuria: From Precision Editing to Clinical Translation

  2025cites this paper
• In vivo base editing reduces liver cysts in autosomal dominant polycystic kidney disease

  2025cites this paper
• Engineered Un1Cas12f1 with boosted gene-editing activity and expanded genomic coverage.

  2025cites this paper
• Development of a universal antibiotic resistance screening system for efficient enrichment of C-to-G and A-to-G base editing.

  2024cites this paper
• Int&in: A machine learning‐based web server for active split site identification in inteins

  2024cites this paper
• Current and Emerging Issues in Adeno-Associated Virus Vector-Mediated Liver-Directed Gene Therapy

  2024cites this paper
• Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies

  2024cites this paper
• Improved split prime editors enable efficient in vivo genome editing.

  2024cites this paper
• AAV-mediated gene therapies by miniature gene editing tools

  2024cites this paper
• Amelioration of metabolic and behavioral defects through base editing in the PahR408W phenylketonuria mouse model.

  2024cites this paper
• Delivering large genes using adeno-associated virus and the CRE-lox DNA recombination system

  2024cites this paper
• Strategies for improving the genome-editing efficiency of class 2 CRISPR/Cas system

  2024cites this paper
• Prime editing: A gene precision editing tool from inception to present

  2024cites this paper
• Targeting the IDH1R132H mutation in gliomas by CRISPR/Cas precision base editing

  2024cites this paper
• Base editing of Ptbp1 in neurons alleviates symptoms in a mouse model of Parkinson’s disease

  2024cites this paper
• The Progress and Promise of Lineage Reprogramming Strategies for Liver Regeneration

  2024cites this paper
• Current developments of gene therapy in human diseases

  2024cites this paper
• Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision

  2024cites this paper
• In vivo liver targeted genome editing as therapeutic approach: progresses and challenges

  2024cites this paper
• Chemical engineering of CRISPR–Cas systems for therapeutic application

  2024cites this paper
• A base editor for the long-term restoration of auditory function in mice with recessive profound deafness

  2024cites this paper
• Targeted mutagenesis of specific genomic DNA sequences in animals for the in vivo generation of variant libraries

  2024cites this paper
• Recapitulating familial hypercholesterolemia in a mouse model by knock‐in patient‐specific LDLR mutation

  2024cites this paper
• Liver gene transfer for metabolite detoxification in inherited metabolic diseases

  2024cites this paper
• Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington’s disease

  2024cites this paper
• nCas9 Engineering for Improved Target Interaction Presents an Effective Strategy to Enhance Base Editing

  2024cites this paper
• Current Advances and Material Innovations in the Search for Novel Treatments of Phenylketonuria

  2024cites this paper
• Response to Harding and Martinez

  2024cites this paper
• Engineering miniature CRISPR-Cas Un1Cas12f1 for efficient base editing

  2024cites this paper
• Viral and nonviral nanocarriers for in vivo CRISPR-based gene editing

  2024cites this paper
• Engineering APOBEC3A deaminase for highly accurate and efficient base editing

  2024cites this paper
• Adeno-associated virus as a delivery vector for gene therapy of human diseases

  2024cites this paper
• Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines.

  2024cites this paper
• In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice

  2024cites this paper
• Comprehensive evaluation and prediction of editing outcomes for near-PAMless adenine and cytosine base editors

  2024cites this paper
• Breaking genetic shackles: The advance of base editing in genetic disorder treatment

  2024cites this paper
• Gene editing in liver diseases

  2024cites this paper
• Treatment of a genetic liver disease in mice through transient prime editor expression

  2024cites this paper
• Exploring noncoding variants in genetic diseases: from detection to functional insights.

  2024cites this paper
• CRISPR technologies for genome, epigenome and transcriptome editing

  2024cites this paper
• Protein language models-assisted optimization of a uracil-N-glycosylase variant enables programmable T-to-G and T-to-C base editing.

  2024cites this paper
• Liver‐directed gene therapy for inherited metabolic diseases

  2024cites this paper
• Precise genome-editing in human diseases: mechanisms, strategies and applications

  2024cites this paper
• A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo

  2024cites this paper
• DNA and RNA base editors can correct the majority of pathogenic single nucleotide variants

  2024cites this paper
• A new compact adenine base editor generated through deletion of HNH and REC2 domain of SpCas9

  2023cites this paper
• Base editors: development and applications in biomedicine

  2023cites this paper
• Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain

  2023cites this paper
• Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1F.

  2023cites this paper
• State‐of‐the‐art 2023 on gene therapy for phenylketonuria

  2023cites this paper
• Rapid and definitive treatment of phenylketonuria in variant-humanized mice with corrective editing

  2023cites this paper
• How CRISPR Is Revolutionizing the Generation of New Models for Cancer Research.

  2023cites this paper
• Gene editing innovations and their applications in cardiomyopathy research

  2023cites this paper
• Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis

  2023influential citation
• Prime editing of the β1 adrenoceptor in the brain reprograms mouse behavior

  2023cites this paper
• Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox

  2023cites this paper
• Current therapies for osteoarthritis and prospects of CRISPR-based genome, epigenome, and RNA editing in osteoarthritis treatment.

  2023cites this paper
• CRISPR for neuroscientists.

  2023cites this paper
• CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective

  2023cites this paper
• Characteristics, Recombination Methods, and Applications Progresses of Split-Cas9 System

  2023cites this paper